Physician profile
Fernando Ramirez Del Val
NPI 1144753526
$9,051.65
in general payments reported to CMS, 2019-2025
11 companies · $8,992 in 2025
The $8,992 reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.15 · 2024: $39.30 · 2025: $8,992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,418 · Food and Beverage: $2,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,418.28 |
| Food and Beverage | $2,613.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,598.53 | 2025 | Mitris Resilia Mitral Valve |
| Angiodynamics, INC. | $2,556.81 | 2025 | Angiovac |
| Artivion, INC. | $2,003.48 | 2025 | Cardiac Non-Synergraft, Cryovalve Sg Pulmonary Human Heart Valve |
| W. L. Gore & Associates, INC. | $867.28 | 2025 | Product In Development |
| Abiomed | $448.57 | 2025 | |
| Medtronic, INC. | $167.89 | 2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $166.90 | 2025 | Ekosonic |
| Baxter Healthcare | $134.97 | 2025 | Floseal |
| Medinc of Texas | $65.14 | 2024-2025 | |
| Ethicon US, LLC | $21.93 | 2025 | Surgiflo Hemostatic Matrix |
| Bsn Medical INC | $20.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Ramirez Del Val listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.